A Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Characteristics, and Preliminary Efficacy of HLX35 in Combination With HLX10 in Patients With Advanced or Metastatic Solid Tumors
Clinical trial NCT05442996 · UNKNOWN
Trial details
- NCT number
- NCT05442996
- Sponsor
- Shanghai Henlius Biotech
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-06
- Primary completion
- 2024-04-22
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.